Blood cancer can be fatal if not detected early; innovative biosensors with machine learning optimization enable timely diagnosis by identifying cancer-specific biomarkers in blood, improving survival ...
The FDA could approve the first blood test that can detect multiple cancers, around the end of the year, setting the stage ...
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS), a leader in cancer diagnostics, today announced the launch of the Cancerguard™ test, a new multi-cancer early detection (MCED) ...
A new light-based sensor can spot incredibly tiny amounts of cancer biomarkers in blood, raising the possibility of earlier and simpler cancer detection. The technology merges DNA nanotechnology, ...
A new type of blood test could help detect multiple cancers early. A team of researchers in California studied a new multi-cancer early detection (MCED) test called Galleri, which can reportedly ...
A multicancer early detection (MCED) test was developed and validated in the case-control Circulating Cell-free Genome Atlas (CCGA) study (ClinicalTrials.gov identifier: NCT02889978). Previous ...
The company is running a new platform set up to minimize false negative results as well as avoiding false positives. (Getty Images) Harbinger Health has grabbed $100 million in its latest funding ...
"No cancer signal detected." The blood test results popped up in my online health portal without much fanfare. A doctor would chat about them with me later, congratulating me on the "phew"-worthy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results